Sanofi chief executive Paul Hudson on Thursday said it was vital that any coronavirus vaccine reach all regions, hours after the pharmaceutical giant was admonished by the French government for suggesting some countries would get priority access.
Sanofi's CEO Paul Hudson said Wednesday that if its efforts to find a coronavirus vaccine pan out, he would supply the United States government first because "it's invested in taking the risk", after it expanded a partnership with his company earlier this year. "The most realistic timeline is that we won't have a Covid-19 vaccine in 2020", Muhammad Munir, virologist & lecturer in biomedicine at the Lancaster University, told FRANCE 24.
Sanofi's chief executive Paul Hudson caused fury in France by announcing that USA patients would get first access to a vaccine because Washington is helping to fund the research.
The EU insisted Thursday that any vaccine against the virus must be available fairly to all countries.
"For us, it would be unacceptable if there were privileged access from this or that country under a pretext that would be a monetary pretext", France's state secretary for economy and finance, Agnès Pannier-Runacher, told France's Sud Radio on Thursday.
"Evidently, if Sanofi makes a breakthrough on a vaccine for Covid-19 and it is efficient, it will be made available to all", Olivier Bogillot, the head of Sanofi in France, told BFM TV today.
In light of this, on Thursday, more than 140 world leaders released an open letter calling for a "people's vaccine" that would be available to all for free.
But that would only be possible "if Europeans work as quickly as the Americans", Bogillot told BFM television, saying the U.S. government had pledged to spend "several hundreds of millions of euros".
Treasurer Had A Surplus Of Coughs But A Deficit Of Coronavirus
When speaking in parliament on Tuesday, the treasurer spoke about Australia's unemployment off the back of the pandemic. Schools are scheduled to open in Victoria in early June.
The funding is aimed at developing a coronavirus vaccine and treatments for Covid-19.
"The Americans have been effective in this period".
In April, Sanofi and the pharmaceutical company GlaxoSmithKline both said they wanted to work together on a vaccine against the novel coronavirus. It has instead partnered directly with pharmaceutical companies, contributing half a billion dollars to Johnson & Johnson's vaccine effort and hundreds of millions of dollars to Sanofi and to Moderna, a biotech company in MA teaming with a Swiss company for vaccine manufacturing. The companies have received financial support from the Biomedical Advanced Research and Development Authority (BARDA) of the U.S. Health Department.
It is one of dozens of vaccine projects underway to combat the coronavirus outbreak that originated in China last December.
Trump also said this month: "We are very confident that we're going to have a vaccine.by the end of the year", a prediction that few health experts consider likely.
At the same time, Sanofi also appealed for the European Union to make it easier to get a vaccine to market.
"A vaccine against COVID-19 should be a public good for the world".